Tobacco Regulation As Device Could Be Complicated By FDAMA - Burlington
This article was originally published in The Gray Sheet
FDA's regulation of cigarettes as a drug delivery device is a "hard thing to reconcile" with the FDA Modernization Act, Bruce Burlington, director of the agency's Center for Devices and Radiological Health, said at the recently concluded Health Industry Manufacturers Association annual meeting in Rancho Mirage, California.
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.